US Stock MarketDetailed Quotes

UNH UnitedHealth

Watchlist
  • 608.520
  • -1.680-0.28%
Close Dec 2 16:00 ET
  • 608.520
  • 0.0000.00%
Post 20:01 ET
560.01BMarket Cap39.57P/E (TTM)

UnitedHealth Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
8.55%99.18B
6.61%97.86B
8.40%98.79B
14.09%367.53B
13.81%93.25B
13.66%91.36B
14.68%91.79B
14.23%91.13B
12.92%322.13B
12.34%81.93B
Operating revenue
8.55%99.18B
6.61%97.86B
8.40%98.79B
14.09%367.53B
13.81%93.25B
13.66%91.36B
14.68%91.79B
14.23%91.13B
12.92%322.13B
12.34%81.93B
Cost of revenue
12.78%77.79B
9.69%76.8B
10.89%76.79B
14.77%280.66B
16.99%72.43B
13.18%68.97B
15.37%70.02B
13.51%69.25B
12.20%244.55B
10.23%61.91B
Gross profit
-4.49%21.39B
-3.27%21.06B
0.51%21.99B
11.96%86.87B
3.97%20.82B
15.18%22.39B
12.53%21.77B
16.57%21.88B
15.24%77.59B
19.41%20.03B
Operating expense
-3.64%14.32B
-4.37%14.18B
3.28%15.07B
14.49%58.6B
2.30%14.31B
18.98%14.86B
18.54%14.83B
19.74%14.6B
12.04%51.18B
16.18%13.99B
Depreciation amortization depletion
3.38%1.04B
-0.10%1.02B
2.78%997M
16.82%3.97B
-0.81%974M
21.62%1.01B
27.31%1.02B
23.10%970M
9.57%3.4B
27.37%982M
-Depreciation and amortization
3.38%1.04B
-0.10%1.02B
2.78%997M
16.82%3.97B
-0.81%974M
21.62%1.01B
27.31%1.02B
23.10%970M
9.57%3.4B
27.37%982M
Other operating expenses
-4.15%13.28B
-4.69%13.16B
3.32%14.08B
14.33%54.63B
2.54%13.34B
18.79%13.86B
17.93%13.81B
19.51%13.63B
12.22%47.78B
15.41%13.01B
Operating profit
-6.16%7.07B
-0.92%6.88B
-5.05%6.92B
7.06%28.27B
7.85%6.51B
8.35%7.53B
1.54%6.94B
10.71%7.29B
21.99%26.41B
27.66%6.04B
Net non-operating interest income expense
-28.78%-1.07B
-18.96%-985M
-11.94%-844M
-55.16%-3.25B
-22.78%-830M
-61.63%-834M
-77.30%-828M
-74.13%-754M
-26.02%-2.09B
-56.84%-676M
Non-operating interest expense
28.78%1.07B
18.96%985M
11.94%844M
55.16%3.25B
22.78%830M
61.63%834M
77.30%828M
74.13%754M
26.02%2.09B
56.84%676M
Other net income (expense)
62.79%1.62B
-120.45%-228M
-861.28%-6.08B
101.43%4.09B
37.89%1.18B
94.35%997M
277.97%1.12B
117.44%798M
-12.65%2.03B
5.17%855M
Gain on sale of security
64.79%1.64B
-10.58%997M
26.69%1.01B
101.43%4.09B
37.89%1.18B
94.35%997M
277.97%1.12B
117.44%798M
-12.65%2.03B
5.17%855M
Special income (charges)
---20M
---1.23B
---7.09B
----
----
--0
--0
--0
----
----
-Gain on sale of business
---20M
---1.23B
---7.09B
----
----
--0
--0
--0
----
----
Income before tax
-1.01%7.61B
-21.64%5.67B
-99.99%1M
10.51%29.11B
10.36%6.86B
10.74%7.69B
8.46%7.23B
12.51%7.33B
18.08%26.34B
21.62%6.22B
Income tax
-18.02%1.36B
-20.87%1.24B
-21.57%1.22B
4.63%5.97B
-9.41%1.18B
5.89%1.65B
7.23%1.57B
13.81%1.56B
24.60%5.7B
42.22%1.31B
Net income
3.64%6.26B
-21.85%4.42B
-121.15%-1.22B
12.14%23.14B
15.63%5.68B
12.15%6.04B
8.81%5.66B
12.16%5.77B
16.39%20.64B
17.11%4.91B
Net income continuous Operations
3.64%6.26B
-21.85%4.42B
-121.15%-1.22B
12.14%23.14B
15.63%5.68B
12.15%6.04B
8.81%5.66B
12.16%5.77B
16.39%20.64B
17.11%4.91B
Minority interest income
3.05%203M
12.02%205M
15.34%188M
47.01%763M
49.66%220M
61.48%197M
41.86%183M
34.71%163M
16.11%519M
22.50%147M
Net income attributable to the parent company
3.66%6.06B
-22.98%4.22B
-125.11%-1.41B
11.24%22.38B
14.58%5.46B
11.00%5.84B
7.97%5.47B
11.62%5.61B
16.40%20.12B
16.95%4.76B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.66%6.06B
-22.98%4.22B
-125.11%-1.41B
11.24%22.38B
14.58%5.46B
11.00%5.84B
7.97%5.47B
11.62%5.61B
16.40%20.12B
16.95%4.76B
Basic earnings per share
3.96%6.56
-22.24%4.58
-125.46%-1.53
12.34%24.12
15.82%5.9037
12.08%6.31
8.87%5.89
12.55%6.01
17.13%21.47
17.72%5.0974
Diluted earnings per share
4.33%6.51
-21.99%4.54
-125.71%-1.53
12.65%23.86
15.90%5.83
12.43%6.24
8.99%5.82
12.90%5.95
17.15%21.18
18.08%5.03
Dividend per share
11.70%2.1
11.70%2.1
13.94%1.88
13.91%7.29
13.94%1.88
13.94%1.88
13.94%1.88
13.79%1.65
14.29%6.4
13.79%1.65
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 8.55%99.18B6.61%97.86B8.40%98.79B14.09%367.53B13.81%93.25B13.66%91.36B14.68%91.79B14.23%91.13B12.92%322.13B12.34%81.93B
Operating revenue 8.55%99.18B6.61%97.86B8.40%98.79B14.09%367.53B13.81%93.25B13.66%91.36B14.68%91.79B14.23%91.13B12.92%322.13B12.34%81.93B
Cost of revenue 12.78%77.79B9.69%76.8B10.89%76.79B14.77%280.66B16.99%72.43B13.18%68.97B15.37%70.02B13.51%69.25B12.20%244.55B10.23%61.91B
Gross profit -4.49%21.39B-3.27%21.06B0.51%21.99B11.96%86.87B3.97%20.82B15.18%22.39B12.53%21.77B16.57%21.88B15.24%77.59B19.41%20.03B
Operating expense -3.64%14.32B-4.37%14.18B3.28%15.07B14.49%58.6B2.30%14.31B18.98%14.86B18.54%14.83B19.74%14.6B12.04%51.18B16.18%13.99B
Depreciation amortization depletion 3.38%1.04B-0.10%1.02B2.78%997M16.82%3.97B-0.81%974M21.62%1.01B27.31%1.02B23.10%970M9.57%3.4B27.37%982M
-Depreciation and amortization 3.38%1.04B-0.10%1.02B2.78%997M16.82%3.97B-0.81%974M21.62%1.01B27.31%1.02B23.10%970M9.57%3.4B27.37%982M
Other operating expenses -4.15%13.28B-4.69%13.16B3.32%14.08B14.33%54.63B2.54%13.34B18.79%13.86B17.93%13.81B19.51%13.63B12.22%47.78B15.41%13.01B
Operating profit -6.16%7.07B-0.92%6.88B-5.05%6.92B7.06%28.27B7.85%6.51B8.35%7.53B1.54%6.94B10.71%7.29B21.99%26.41B27.66%6.04B
Net non-operating interest income expense -28.78%-1.07B-18.96%-985M-11.94%-844M-55.16%-3.25B-22.78%-830M-61.63%-834M-77.30%-828M-74.13%-754M-26.02%-2.09B-56.84%-676M
Non-operating interest expense 28.78%1.07B18.96%985M11.94%844M55.16%3.25B22.78%830M61.63%834M77.30%828M74.13%754M26.02%2.09B56.84%676M
Other net income (expense) 62.79%1.62B-120.45%-228M-861.28%-6.08B101.43%4.09B37.89%1.18B94.35%997M277.97%1.12B117.44%798M-12.65%2.03B5.17%855M
Gain on sale of security 64.79%1.64B-10.58%997M26.69%1.01B101.43%4.09B37.89%1.18B94.35%997M277.97%1.12B117.44%798M-12.65%2.03B5.17%855M
Special income (charges) ---20M---1.23B---7.09B----------0--0--0--------
-Gain on sale of business ---20M---1.23B---7.09B----------0--0--0--------
Income before tax -1.01%7.61B-21.64%5.67B-99.99%1M10.51%29.11B10.36%6.86B10.74%7.69B8.46%7.23B12.51%7.33B18.08%26.34B21.62%6.22B
Income tax -18.02%1.36B-20.87%1.24B-21.57%1.22B4.63%5.97B-9.41%1.18B5.89%1.65B7.23%1.57B13.81%1.56B24.60%5.7B42.22%1.31B
Net income 3.64%6.26B-21.85%4.42B-121.15%-1.22B12.14%23.14B15.63%5.68B12.15%6.04B8.81%5.66B12.16%5.77B16.39%20.64B17.11%4.91B
Net income continuous Operations 3.64%6.26B-21.85%4.42B-121.15%-1.22B12.14%23.14B15.63%5.68B12.15%6.04B8.81%5.66B12.16%5.77B16.39%20.64B17.11%4.91B
Minority interest income 3.05%203M12.02%205M15.34%188M47.01%763M49.66%220M61.48%197M41.86%183M34.71%163M16.11%519M22.50%147M
Net income attributable to the parent company 3.66%6.06B-22.98%4.22B-125.11%-1.41B11.24%22.38B14.58%5.46B11.00%5.84B7.97%5.47B11.62%5.61B16.40%20.12B16.95%4.76B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.66%6.06B-22.98%4.22B-125.11%-1.41B11.24%22.38B14.58%5.46B11.00%5.84B7.97%5.47B11.62%5.61B16.40%20.12B16.95%4.76B
Basic earnings per share 3.96%6.56-22.24%4.58-125.46%-1.5312.34%24.1215.82%5.903712.08%6.318.87%5.8912.55%6.0117.13%21.4717.72%5.0974
Diluted earnings per share 4.33%6.51-21.99%4.54-125.71%-1.5312.65%23.8615.90%5.8312.43%6.248.99%5.8212.90%5.9517.15%21.1818.08%5.03
Dividend per share 11.70%2.111.70%2.113.94%1.8813.91%7.2913.94%1.8813.94%1.8813.94%1.8813.79%1.6514.29%6.413.79%1.65
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Donald Trump
Donald Trump
Intraday+0.25%